Publications

This issue explores Massachusetts’ trends in psychotropic medication prescriptions, including medications for substance use disorder (SUD), among commercially-insured Massachusetts residents between the ages of 5 and 64 with full-year pharmacy coverage in the Massachusetts All-Payer Claims Database from 2019 – 2024.

Presented at the 2026 AcademyHealth Annual Research Meeting

This issue of the HPC’s DataPoints series identifies pharmacy deserts – communities without convenient access to a pharmacy and the medication and services they provide – across the state, as well as “near-deserts” – communities that are vulnerable to becoming pharmacy deserts.

Presented at the 2025 AcademyHealth Annual Research Meeting

Presented at the 2025 AcademyHealth Annual Research Meeting

This issue of the HPC's DataPoints series explores trends in polypharmacy, or the use of five or more prescription medications, among commercially-insured adults in Massachusetts, including the characteristics of individuals with polypharmacy and trends in their care utilization.

In this annual report for 2024, the HPC presents new research to enhance the collective understanding of health care spending trends and cost drivers and evaluates progress in meeting the Commonwealth’s cost containment, care delivery, and payment system goals.

This issue of the HPC’s DataPoints series explores trends in GLP-1 prescriptions in Massachusetts through September 2023 and examines the use and spending impacts of these drugs in the Commonwealth.

Presented at the 2024 AcademyHealth Annual Research Meeting

In this annual report for 2023, the HPC presents new research to enhance the collective understanding of health care spending trends and cost drivers and evaluates progress in meeting the Commonwealth’s cost containment, care delivery, and payment system goals.